Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20060314 : Essai de phase 2 évaluant l’efficacité et la tolérance de l’association du panitumumab à une chimiothérapie de type FOLFIRI (irinotécan, 5-FU et acide folinique), chez des patients ayant un cancer colorectal métastatique. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A single arm multicentre phase II study of panitumumab in combination with Irinotecan/5-Fluorouracil/Leucovorin in patients with metastatic colorectal cancer.
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Soins Palliatifs
,
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study to Assess the Efficacy and Safety of Romosozumab Treatment Compared to Alendronate in Postmenopausal Women with Osteoporosis
For the primary analysis period (randomization to primary analysis) • To assess the effect of romosozumab treatment for 12 months followed by alendronate (ALN) treatment compared with ALN treatment a...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Safety and Efficacy of Brodalumab in Subjects With Axial Spondyloarthritis
To evaluate the efficacy of brodalumab in ankylosing spondylitis (AS) compared to placebo, as measured by the proportion of AS subjects achieving an Assessment of SpondyloArthritis international Socie...
Country
None
organs
None
Specialty
None
Closed trial
More information
Amgen (UK)
Update Il y a 4 ans
Prospective randomised evaluation of high-intensity chemotherapy with peripheral blood progenitor support in patients with high risk breast cancer
Not provided at time of registration
Country
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancer
To determine the effect of AMG 706 on the objective response rate (complete response and partial response) in subjects with locally advanced or metastatic thyroid cancer in each of 2 strata: medullary...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
KAI Pharmaceuticals, Inc. (a subsidiary of Amgen, Inc.)
Update Il y a 4 ans
A study of AMG 416 in the treatment of secondary hyperparathyroidism in chronic kidney disease
To evaluate the efficacy and safety of AMG 416 in the treatment of secondary hyperparathyroidism (SHPT) in subjects with chronic kidney disease (CKD) on hemodialysis. Primary: To evaluate the effi...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
The primary objective of this study is to evaluate the efficacy of AMG 531 in the treatment of thrombocytopenia in subjects with ITP refractory to splenectomy as measured by the durable platelet respo...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years and 95 years
Amgen
Update Il y a 4 ans
Étude KEYNOTE-034 : étude de phase 1b/3 randomisée comparant le pembrolizumab seul au pembrolizumab en association au talimogène laherparepvec chez des patients ayant un mélanome non résécable de stade IIIB à IVM1C. [essai clos aux inclusions]
Le mélanome est une tumeur maligne qui prend naissance dans les cellules de la peau, les mélanocytes. Un changement de la couleur, de la taille ou de la forme d’un grain de beauté est souvent le premi...
Country
France
organs
Mélanomes cutanés
Specialty
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen Development Europe
Update Il y a 4 ans
Study to Investigate Cinacalcet Treatment in Haemodialysis Patients with Secondary Hyperparathyroidism
To demonstrate that the efficacy of cinacalcet when co-administered with the first meal after dialysis is comparable (non-inferior) to the efficacy of cinacalcet when administered during the dialysis ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study to assess the long term safety and efficacy of evolocumab in patients with a waxy substance (plaque) in the arteries of the heart
To characterize the safety and tolerability of long-term administration of evolocumab in subjects with known coronary artery disease and hypercholesterolemia
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next